trial

Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)

NCTId NCT00790517
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 200 (actual)
Sponsored by Kaiser Permanente
Primary completion 2014-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
200 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2009-06
Primary completion
2014-09
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Premier Lifestyle Intervention with DASH Diet

Sponsors

Kaiser PermanenteLead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
LifeWorks NorthwestCollaborator
Cascadia Behavioral HealthcareCollaborator

Investigators

1
Carla A. Green, PhD, MPHPrincipal Investigator

Sites

3 total
Portland, United StatesPortland, United StatesPortland, United States

Linked catalysts

1
Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE) — primary completion2014-09

Facts & assertions

4 sourced
Enrollment
200
Phase
PHASE2
Primary Completion Date
2014-09
Status
COMPLETED
relationships
The graph out of here
drug
Premier Lifestyle Intervention with DASH Diet
drug
lead_sponsor
Kaiser Permanente
company
collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
company
LifeWorks Northwest
company
indication
Psychotic Disorders
indication
Weight Loss
indication
Diabetes Mellitus, Type 2
indication
investigator
Carla A. Green, PhD, MPH
person